Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 80 for “"chelation therapy"”.
-
Stereoisomeric selectivity of 2,3-dimercaptosuccinic acid in chelation therapy for heavy metal poisoning.
Racemic-2,3-dimercaptosuccinic acid (rac-DMSA)¹ was synthesized and its structure in the solid state was studied by single crystal X-ray analysis. The three-dimensional structure of rac-DMSA solid is stabilized by van der Waals forces, whereas the meso-DMSA solid is stabilized by hydrogen bonding. …
-
Melanin nanoparticles as a potential iron chelation therapy for women with beta thalassemia during pregnancy
… to the complication of iron overload. Current chelation medications are withheld during pregnancy as they can cross the placenta causing potential risk to the foetus. This thesis addressed this complicated challenge in which a chelation agent needs to be retained in the maternal circulation and …
-
The Effects of EDTA Chelation Therapy on Plaque Calcium and Mineral Metabolism in Atherosclerotic Rabbits
… six weeks after completion of EDTA chelation therapy.
-
Assessment of Iron Chelation Therapy in an Atherosclerotic Animal Model of Intraplaque Red Blood Cell Deposition
… open significantly narrowed vessels and medical therapy to address modifiable risk factors such as high cholesterol. However, there are no therapeutics targeted towards intraplaque hemorrhage. This thesis aims to test the effectiveness of iron chelation therapy in removing plaque iron and …
-
Targeted EDTA Chelation Therapy with Albumin Nanoparticles to Reverse Arterial Calcification and Restore Vascular Health in Chronic Kidney Disease
… we tested the targeted nanoparticle-based EDTA chelation therapy in a rat model of adenine-induced renal failure. The targeted nanoparticles delivered EDTA at the sites of vascular calcification and reversed mineral deposition without any side effects. Furthermore, we validated the adenine-CKD …
-
The crisis of iron in transfusion medicine : improved iron chelation therapy and its implications for clinical practice in the Maldives
… infections in these patients. Current iron chelation therapy using Desferal® (DFO) is challenging due to its short vascular half-life, frequency of injections, toxicity and expense. To address this problem, we have tested novel, low toxicity, high molecular weight (HMW) iron chelators. The …
-
MECHANISMS AND REVERSAL OF ELASTIN SPECIFIC MEDIAL ARTERIAL CALCIFICATION
… there is no available alternative to surgical therapy for reversal of vascular calcification. One possible approach is EDTA chelation therapy. EDTA chelation therapy most often involves the injection of disodium ethylene diamine tetraacetic acid (EDTA), a chemical that binds, or chelate ionic …
-
Αποσιδήρωση παιδιών και εφήβων με ομόζυγη β-μεσογειακή αναιμία με νέο θεραπευτικό σχήμα: έλεγχος επίδρασης στο νευρικό και ανοσιακό σύστημα
… thalassaemia includes blood transfusions and chelation therapy. Chelation therapy is being demonstrated since 1978 by the use of subcutaneous desferrioxamine. Because of this painful therapeutic procedure, a new method had to be found, which should be more usable, like the application of a …
-
Using iron deficiency stress in plants as a tool for discovery of novel iron chelators for human use
… (PD). Treatments for iron overload can include chelation therapy to bind iron and remove it from tissues, but options authorized for clinical use are limited and can cause severe side effects. Plants are a good source of specialized, bioactive metabolites, and may be an untapped resource for …
-
Determination of Total and Unfilterable Plasma Aluminum in Uremic Patients
… aluminum loading and of the effectiveness of chelation therapy. Aluminum which is in the ultrafilterable state may cross a dialysis membrane and be removed from the body. Aluminum analyses were conducted by polarized Zeeman-effect atomic absorption spectrophotometry. The sensitivity was …
-
The role of haem transport and iron chelation in oesophageal cancer
… haem and to explore the potential of iron chelation therapy in the treatment of oesophageal cancer. Haem import proteins are sequentially over expressed in the evolution of OAC. Culturing OAC cells with supplementary haem significantly enhances viability, proliferation, migration and …
-
Συσχέτιση των μοριακών διαταραχών του γονιδίου της νόσου Wilson (ATP7B) με τον κλινικό και βιοχημικό φαινότυπο της νόσου
… and brain. Patients left without treatment (chelation therapy) present neurological signs and/or hepatic disease. Wilson disease is caused by mutations in the ATP7B gene and exhibits substantial allelic heterogeneity. In this study we report the results of molecular analysis of 93 patients …
-
Beta thalassemia: pathogenesis, progression, and treatment
… for the disease is transfusions and iron chelation therapy, and the only cure is hematopoietic stem cell transplantation. In recent years, however, multiple treatments and potential cures such as fetal hemoglobin inducers and gene therapy have shown promise. By analyzing the …
-
Beta thalassemia-induced osteoporosis: evaluating current and novel therapeutic options
… through regular blood transfusions and iron chelation therapy. With several, complex genetic and acquired factors involved in its pathogenesis, coupled with the heterogeneity in the clinical response of BTM patients to different pharmacological agents, OOS has proven to be particularly …
-
Oxidation and reduction of inorganic arsenic in mammalian systems
… sensitivity. Second, it suggests that iron chelation therapy might be beneficial in conjunction with arsenic chelation therapy for patients suffering from acute arsenic poisoning.
-
Ηλεκτροφυσιολογική μελέτη οφθαλμών σε ασθενείς με βήτα μεσογειακή αναιμία
… transfusions or retinal toxicity induced by chelation therapy. Purpose: The purpose of this study was to assess the role of various diagnostic tests in early detection of retinal changes in β-thalassemia major (β-ΤΜ) patients. Materials & Methods: Thirty-eight visually asymptomatic β-ΤΜ …
-
Μελέτη της κόπωσης ως χρόνιο σύμπτωμα σε ασθενείς με αιμοσφαιρινοπάθειες
… with hemoglobinopathies under transfusion therapy, from 2 Thalassaemia Transfusion Centers (TTC) of major urban cities and 3 TTC from rural cities participated in the study. Multidimentional Fatigue Inventory (MFI), Depression, Anxiety and Stress scale (DASS), Euro5D thermometer for the …
-
Role of glutamate in lead-induced toxicity: protection by N-acetylcysteine amide (NACA), a novel thiol antioxidant
… kinase C (PKC) resulting in oxidative stress. Chelation therapy has been a choice to reduce the body burden of lead; however chelation does not eliminate the neurotoxicity of lead...In this study we propose to evaluate the involvement of glutamatergic component in lead-induced toxicity and also …
-
Physicochemical characterization of chelation and transport of iron by low molecular weight chelators
… applications of chelating agents, both for chelation therapy and for antimicrobial agents.</p> <p>The thermodynamics of iron(III) binding of a number of molecules, both natural and synthetic, are determined using pH-dependent spectrophotometric titrations and potentiometric titrations . …
-
Μελέτη κινητικής οξυγόνου σε β-ομόζυγους μεσογειακούς ασθενείς
… to treatment, based on regular transfusions. Chelation therapy reduces iron load and prevents secondary hemosiderosis effects. Despite the introduction of intensified transfusions and iron chelation therapy in TM patients that has markedly reduced the incidence of heart failure and has …
Page 1 of 4